STVN Stevanato: Earnings per share for the last 12 months

Stevanato Group Corp (STVN) - corporate logo

Stevanato Group S.p.A. maintains a duopoly in the premium glass packaging segment, benefiting from the demand for GLP-1 drugs. The GURU.Markets interface displays this chart, where the annual EPS TTM growth rate has reached 4.90, reflecting current profit levels. The company generates revenue from the production of vials and syringes, yet faces pressure from declining customer inventories and energy prices.

STVN Stevanato Group Corp: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/17/2026

Financial and market metric breakdowns for Stevanato Group Corp (STVN)

- market price and analyst price targets:
Initial company analysis:Stevanato Group S.p.A.
Product sample of Stevanato

This indicator measures the rate of change in net earnings per share over a rolling year, allowing for a real-time assessment of business resilience to market shocks. By analyzing the annual EPS (TTM) change, an investor determines the stability of returns for Stevanato Group S.p.A. amid volatile vaccine demand and inflationary pressure on the cost of specialized glass raw materials.

Competitor analysis for Stevanato Group S.p.A.

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Teleflex Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|Dentsply Sirona Inc (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months LeMaitre Vascular|ATRC (atricure.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co STAA|Earnings per share for the last twelve months ChromaDex (NAGE)|ZimVie - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CERS (Cerus Corp.)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Orthopedics Inc. MGRM|Sharps Technology, Inc. (STSS) - Earnings per share for the last twelve months|INFU - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months UTMD|Net earnings per one share for the last twelve months korumedical.com KRMD|Net earnings per share for the last 12 months NYXH (Nyxoah S.A.)|Net earnings per share for the last 12 months Microbot Medical, Inc MBOT|Pro-Dex Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ZTEK (Zentek Ltd.)|Elutia Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Milestone Scientific Corp MLSS|NEXGEL, Inc (NXGL) - Earnings per share for the last twelve months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)